Clinical Trial Update: Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS [NA]

View source ↗

Summary

Completed clinical trial evaluating non-inferiority and tolerability of the PHOS-ISTOS device for actinic keratosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PHOS-ISTOS

Snippet

Sponsor: University Hospital, Lille | Conditions: Keratosis, Actinic | NA | Status: COMPLETED